[ad_1]
Cali –
Improve the early diagnosis of these diseases and other diseases such as bad cancer, hemophilia A (defective blood clotting) and multiple sclerosis (chronic disease of the nervous system) is the challenge in Latin America.
Daniel Ciriano, Regional Medical Director of Roche for Latin America, said at a forum for journalists in Cali, Colombia
"If cancer evolves, it affects the person more and shorten his life. " According to Ciriano, this is mainly due to the lack of access or the difficulty of access of communities to the health system, the figures increase.
For example, bad cancer, which, according to Roche, is the most common disease among women, with 1.67 million cases detected each year in the world. Likewise, every minute a patient dies of this disease.
On the other hand, multiple sclerosis, which affects the nervous system, is affected by 2.3 million people.
Ciriano argues that it is possible to detect it in time. He advises to perform the test at those between 20 and 40.
Breast cancer and multiple sclerosis are not the only diseases that are not detected early, for this reason each country needs to be tested. education and awareness.
the progress of medicine, but also the delays. "In the case of bad cancer, 70% of diseases are detected in an advanced state," said Carlos Estrada, managing director of Roche Colombia.
For his part, Rolf Hoenger, pharmaceutical leader for Latin America, He pointed out that in many cases the treatments are not adequate because they are not treated according to the stage and of the type of the disease.
More than 20 countries participate in the event: Ecuador, Peru, Colombia, Venezuela, El Salvador, Argentina Bolivia, Costa Rica and Brazil.
Roche is an international company that conducts clinical studies and runs events every year to raise awareness of the shortcomings and how to work on them on the continent such as personalized bad cancer vaccines. . (I)
[ad_2]
Source link
